BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19443395)

  • 1. Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
    Hirose T; Sugiyama T; Kusumoto S; Shirai T; Nakashima M; Yamaoka T; Okuda K; Ogura K; Ohnishi T; Ohmori T; Adachi M
    Anticancer Res; 2009 May; 29(5):1733-8. PubMed ID: 19443395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.
    Okamoto I; Moriyama E; Fujii S; Kishi H; Nomura M; Goto E; Kiyofuji C; Imamura F; Mori T; Matsumoto M
    Jpn J Clin Oncol; 2005 Apr; 35(4):188-94. PubMed ID: 15845567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.
    Okuda K; Hirose T; Ishida H; Kusumoto S; Sugiyama T; Ando K; Shirai T; Ohnishi T; Horichi N; Ohmori T; Adachi M
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):829-35. PubMed ID: 17589845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study.
    Hasegawa Y; Takanashi S; Okudera K; Aoki M; Basaki K; Kondo H; Takahata T; Yasui-Furukori N; Tateishi T; Abe Y; Okumura K
    Jpn J Clin Oncol; 2004 Nov; 34(11):647-53. PubMed ID: 15613553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer.
    Inoue A; Usui K; Ishimoto O; Matsubara N; Tanaka M; Kanbe M; Gomi K; Koinumaru S; Saijo Y; Nukiwa T
    Lung Cancer; 2006 Apr; 52(1):83-7. PubMed ID: 16483687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with carboplatin and weekly Paclitaxel in patients with advanced non-small cell lung cancer].
    Hashizume T; Ogura T; Kozawa S; Yamaguchi N; Hayashi M; Nakamura M; Miyazawa N; Watanuki Y; Takahashi H
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):471-5. PubMed ID: 16612156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
    Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ
    J Clin Oncol; 2008 Jan; 26(3):468-73. PubMed ID: 18202422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
    Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancer.
    Ozawa Y; Inui N; Naitoh T; Yasuda K; Nagayama M; Shirai T; Suganuma H; Fujii M; Nakamura H; Suda T; Chida K
    Lung Cancer; 2009 Jan; 63(1):68-71. PubMed ID: 18513824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
    Charoentum C; Thongprasert S; Chewasakulyong B
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
    Tell R; Sederholm C; Klintenberg C; Franksson L; Brandén E; Hillerdal G; Lönn U; Lindén CJ; Ewers SB; Lamberg K; Mrazek E; Lödén B; Sjögren A; Linné T; Friesland S; Sirzén F
    Anticancer Res; 2008; 28(5B):2851-7. PubMed ID: 19031924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC).
    Giorgio CG; Pappalardo A; Russo A; Giuffrida D; Santini D; Petralia G; Castorina S; Nunzio R; Failla G; Bordonaro R
    Lung Cancer; 2006 Mar; 51(3):357-62. PubMed ID: 16406602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of a biweekly regimen of vinorelbine and cisplatin in advanced non-small cell lung cancer.
    Chen CH; Lin CM; Kao KC; Chang JW; Tsao TC
    Chang Gung Med J; 2007; 30(3):249-55. PubMed ID: 17760276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: a phase I-II trial.
    Stathopoulos GP; Dimitroulis J; Toubis M; Katis C; Karaindros D; Stathopoulos J; Koutandos J
    Lung Cancer; 2007 Jul; 57(1):66-71. PubMed ID: 17382431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
    Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
    Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer.
    Nakadate M; Yamazaki K; Konishi J; Kinoshita I; Sukoh N; Harada M; Akie K; Ogura S; Ishida T; Munakata M; Dosaka-Akita H; Isobe H; Nishimura M
    Anticancer Res; 2006; 26(5B):3767-72. PubMed ID: 17094399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly paclitaxel in patients with advanced lung cancer: preliminary data from a phase II trial.
    Akerley W; Choy H; Safran H; Sikov W; Rege V; Sambandam S; Wittels E
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-10-S12-13. PubMed ID: 9331112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy.
    Yoh K; Kubota K; Kakinuma R; Ohmatsu H; Goto K; Niho S; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Oct; 58(1):73-9. PubMed ID: 17548127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
    Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
    Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.